This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: E&s Healthcare Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovations of Dong Woo Lim
Introduction
Dong Woo Lim is a notable inventor based in Sejong, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. His work focuses on addressing skin conditions, specifically acne, through innovative scientific techniques.
Latest Patents
Dong Woo Lim holds a patent for a "Human antibody specifically binding to acne bacteria using phage display technique, and use thereof." This invention relates to a human antibody that specifically targets acne-inducing bacteria using phage display technology. The patent encompasses an antibody that binds to a specific antigen, a human antibody that includes this binding capability, and the application of phage display technology. Additionally, it covers cosmetic and pharmaceutical compositions that utilize this innovative antibody.
Career Highlights
Lim is associated with E&S Healthcare Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in creating solutions for acne treatment, which can significantly improve the quality of life for many individuals suffering from this common skin condition.
Collaborations
Some of his notable coworkers include Eun Hye Kang and Kyong Hoon Suh. Their collaborative efforts contribute to the innovative environment at E&S Healthcare Co., Ltd., fostering advancements in healthcare solutions.
Conclusion
Dong Woo Lim's contributions to biotechnology, particularly in the development of targeted human antibodies, highlight his role as an influential inventor in the field. His innovative work continues to pave the way for effective treatments for acne, showcasing the importance of research and collaboration in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile